ASNC Leaders Field 40+ Meetings with Congressional Offices

Fourteen ASNC members traveled to Washington, DC, where they participated in more than 40 meetings with Members of Congress and their staff. In preparation, the physicians attended in-depth training sessions focused on the details of legislation under consideration in one or both houses of Congress. The bills included provisions around topics such as physician payment, prior authorization, and the appropriate use criteria mandate.

ASNC’s Capitol Hill Advocates

ASNC’s Delegation on Capitol Hill

ASNC thanks these members who took time to participate in ASNC’s advocacy work on Capitol Hill:

• Jamieson M. Bourque, MD, MHS, FASNC
• Panithaya Chareonthaitawee, MD
• Rami Doukky, MD, MSc, MBA, FASNC
• Attila Feher, MD, PhD
• Stephen Horgan, MB, BCh, PhD
• Daniel Huck, MD, MPH
• Friederike Keating, MD, FASNC
• Lawrence Phillips, MD, MASNC
• Ibrahim M. Saeed, MD, FASNC
• Rupa Sanghani, MD, FASNC
• Nishant Shah, MD, MPH, MS, FASNC
• Suman Tandon, MD, FASNC
• Vikas Veeranna, MD
• David E. Winchester, MD, MS, FASNC

Radiopharmaceuticals and Tariffs

From left: Rupa Sanghani, MD, FASNC, and ASNC President Panithaya Chareonthaitawee, MD, met with congressional leaders about the Commerce Department’s section 232 investigation into potential tariffs on radiopharmaceuticals.

ASNC’s day on Capitol Hill also included targeted meetings on the Commerce Department’s section 232 investigation, which will result in recommendations to the Trump Administration on potential tariffs on radiopharmaceuticals. The ASNC team, led by ASNC President Panithaya Chareonthaitawee, MD, and Rupa Sanghani, MD, FASNC, explained the fragility of the U.S. radiopharmaceutical supply and asked that any tariffs on these agents be deferred at least until a domestic source is established.

ASNC keeps members informed with alerts announcing health policy news and analysis of evolving issues. To ensure you receive ASNC’s advocacy alerts, be sure to keep your membership current.

Join or Renew Today